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ABSTRACT 
 
Introduction: The optimal imaging time of a radionuclide scintigraphy is the time at which the organ of interest has the maximum 
uptake of the injected radionuclide. This study was performed to investigate the maximum uptake time of 99mTc-DMSA in rat renal 
scan.  
Methods: Renal scintigraphy was performed with 3 mCi of 99mTc-DMSA. Planar images were acquired every 20 minutes for 8 hours 
post-injection using a small-animal SPECT. 
Results: Activity and the count rate per pixel (CRPP) of the kidneys peaked 1 h post-injection, plateaued for about 1 h, and declined 
time-dependently. Kidney to background ratio (KBR) reached to 61.7% at 1 h after injection and remained almost constant afterwards.  
Conclusion: The kidneys had maximum emission and CRPP between 1 to 2 h after 99mTc-DMSA injection, whereas there was no 
significant difference between the KBRs after 1 h. Our results showed that image acquisition of 1-2 h post-injection is recommended 
for renal scintigraphy with DMSA in rat. 
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INTRODUCTION 
Radionuclide imaging techniques are widely used in 
preclinical and clinical studies [1]. Recent 
development of small-animal SPECT imaging 
systems can be applied for quantitative in vivo 
imaging using gamma-emitter radionuclides [2]. Such 
modalities provide non-invasive methods for the 
assessment of pharmacological parameters in living 
animals. 
The time course of radionuclide concentration in the 
organs of interest depends on the tracer itself as well 
as the organ physiology. The interval between 
injection and acquisition as well as the duration of 
acquisition time should be optimized for each 
radiotracer [3, 4].   
Renal scintigraphy using dimercaptosuccinic acid 
labeled with Technetium-99m (99mTc-DMSA) is 
considered as the protocol of choice for the assessment 
of relative renal function and cortical integrity in 
clinical practice [5, 6]. It is also implemented for the 
investigation of renal disorders using animal models in 
several preclinical studies [2, 7, 8]. Although a period 
of 2 to 6 hours have been used in different studies [7, 
9, 10], the optimal time of imaging is yet to be 
elucidated. Having a detailed understanding of the 
distribution of the radionuclide helps find the 
appropriate time of imaging which would be the time 
of maximum uptake of the radionuclide in the organ of 
interest. 
In this study we investigated the time of maximum 
uptake of 99mTc-DMSA scan in rats with a dedicated 
dual-headed gamma camera for small-animal 
radionuclide imaging. 
 
METHODS 
Imaging system 
Imaging was conducted using HiReSPECT, a small-
animal SPECT. The imaging system consisted of two 
gamma cameras containing two flat panel PSPMTs 
with an active detection area of about 100 mm × 50 
mm. Each pair of H8500C PSPMTs had been fixed to 
a CsI(Na) crystal (80×38 pixel) with pixel size of 1mm 
×1mm ×5 mm. Each head was equipped with a high 
resolution parallel-hole collimator. The image spatial 
resolutions and the planar spatial resolution of the 
system at the head surface were 1.2–1.6 mm and 1.7 
mm, respectively. The system sensitivity at the 
collimator surface and 8 cm from the collimator 
surfaces were about 1.30 cps/mCi and 1.18 cps/mCi, 
respectively [11, 14]. 
 
Animal scan 
Pertechnetate 99mTcO4 was eluted from technetium-
99m generator containing molybdenum-99. The 
extracted 40 mCi of activity was added to 99mTc-
DMSA kit vial in accordance with the manufacturer’s 
instructions. Briefly, normal saline was added to the 
vial content to reach a final volume of 2 ml. The vial 
was then shook vigorously for 1 min, and incubated at 
room temperature for 10 min. The radiotracer 
activities in syringe were measured using a dose-
calibrator (CRC-25R, Capintec, Inc.) before and after 
the injection. 
Time course of the maximum radionuclide uptake in 
the kidneys was evaluated by injection of 3 mci of 
99mTc-DMSA in 3 rats. The tracer was administered 
through the tail vein under general anesthesia; animals 
were anaesthetized with Ketamine (100 mg/kg) and 
Xylazine (10 mg/kg). Imaging was carried out 20 min 
after DMSA delivery and continued for 8 h post-
injection. Two opposed (ventral and dorsal) images 
were acquired every 20 min.  
All Animal experiments performed in accordance to 
the ethic committee of animal research instructions. 
 
Image analysis 
Regions of interest (ROI) were drawn manually 
around the kidneys and small areas of surrounding 
tissue as backgrounds for each kidney. After 
background correction, the distribution of the activity 
in each kidney calculated by geometric mean of the 
counts within the ROIs in anterior and posterior 
images. The sum of calculated left and right kidney 
counts was assigned as total uptake. Kidney uptakes 
were expressed as the number of photon counts, count-
rate-per-pixel (CRPP) and the relative kidney uptake 
which calculated as kidney count to background 
counts ratio (KBR). 
 
RESULTS 
Figure 1 depicts the uptake of 99mTc-DMSA in the 
kidneys over a time span of 8 h post-injection. The 
background activity was approximately twice that of 
the kidneys 20 min post-injection. While the former 
declined gradually, the latter increased over time 
(Figure 1a). In particular, kidney counts boomed 
dramatically over the next 20 min, and continued to 
increase reaching its peak at 1 h post-injection. Then, 
it remained almost constant for 60 min, after which it 
began to decline time-dependently. The CRPP 
followed a similar pattern (Figure 1b). It increased 
from 1.89 at 20 min post-injection to 3.17 in 1 h. Then, 
it remained almost constant for 60 min and decreased 
to 1.89 at the end of the experiment.  
Initial KBR was 37.6%. It climbed significantly to 
57% over the next 20 min. then, the slope decreased 
reaching a plateau after 1 h, and maintained almost the 
same level over the timespan of study (Figure 1c).   
Figure 1 indicates that the activity concentration in the 
kidney peaked at 60 min after injection and remained 
unchanged for 1 h.  
Maximum uptake time of 99mTc-DMSA  
Tanha et al. 
 
 
Ir
an
 J
 N
uc
l M
ed
 2
01
7,
 V
ol
 2
5,
 N
o 
2 
(S
er
ia
l N
o 
49
) 
  
  
  
  
 h
tt
p:
//
ir
jn
m
.t
um
s.
ac
.ir
  
  
  
  
  
Ju
ly
, 
20
17
 
112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. The uptake of 99mTc-DMSA in the kidneys over a time span of 8 h post-injection. 
 
Hence, the relative activity of the kidney in a specific 
time was calculated by normalizing the kidney counts 
at that time to the activity at 2 h post-injection. 
Physical ( ௣ܶ) and biological ( ௕ܶ) half-lives of 99mTc-
DMSA are 6 h and 6.5 days, respectively [15]. 
Calculated effective half-life ( ௘ܶ ) was obtained from 
formula 1, and found to be 346.7 min. Tୣ = T୮ × TୠT୮ + Tୠ   (Formula 1) 
Radionuclide decay rate was calculated from formula 
2. The calculated half-life of 99mTc-DMSA found to be 
408.5 min which is comparable to its physical and 
effective half-lives (Figure 1d). N = N଴ eି  ୪୬ଶ୲భ మൗ   ୲  (Formula 2) 
Figure 2 shows the planar images of the rats. As 
indicated in the figure, the kidneys have maximum 
uptake at the 2nd hour post-injection. After 2 h kidney 
counts as well as the background activity declined 
over the time. This leads to an almost constant KBR 
which indicated in the Figure 1c. 
 
DISCUSSION 
Renal scintigraphy using 99mTc-DMSA is the preferred 
method for the assessment of kidney function [16, 17]. 
However, data about the appropriate time of this 
radionuclide imaging is limited [2, 7, 8]. The time 
interval between radionuclide injection and imaging in 
these studies varies from 2 to 6 h [3, 18, 19]. In this 
study we aimed to find the appropriate time of imaging 
for 99mTc-DMSA renal scintigraphy using a parallel 
hole dual-head small-animal imaging system.  
The amount of kidney counts increased over time to 
reach a plateau at 1 h post-injection (Figure 1a). After 
peaking, kidney count plateaued for about 1 h and 
declined in a time-dependent manner. The KBR 
summited at 1 h after injection and remained almost 
constant over the course of experiment. This implies 
that after reaching the plateau both the background and 
kidney counts decreased with the same coefficient. 
The results of this study are comparable to that of 
Taylor et al. They studied the biodistribution of 
DMSA in rats at 0.5, 2, and 24 h after injection. They 
showed that radionuclide renal uptake reached to its 
maximum 0.5 h after injection, and remained constant 
for 24 h. In addition, they found that background 
activity decreased substantially, and KBR was 
considerably higher at 24 h than at the other two points 
[3]. 
Figure 1a indicates that the kidney count had a peak 
value at 1 h post-injection and decreased after 2 h. 
Considering the physical half-life of the 99mTc (about 
6 h), the biological half-life of the 99mTc-DMSA (about 
6.5 days) [15] and calculated effective half-life of this 
radionuclide (346.7 min), we found an agreement 
between the decrease of kidney counts over time with 
the curve of 99mTc-DMSA physical decay. As depicted 
in Figure 1d, the amount of kidney count decreased 
time-dependently with a half-life of close to the 
physical and effective half-lives, while the ratio of the 
kidney counts to background counts is constant.  
Maximum uptake time of 99mTc-DMSA  
Tanha et al. 
 
 
Ir
an
 J
 N
uc
l M
ed
 2
01
7,
 V
ol
 2
5,
 N
o 
2 
(S
er
ia
l N
o 
49
) 
  
  
  
  
 h
tt
p:
//
ir
jn
m
.t
um
s.
ac
.ir
  
  
  
  
  
Ju
ly
, 
20
17
 
113 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. Renal scintigraphy with 99mTc-DMSA in rats (the planar images). 
 
 
The results of this experiment are comparable to that 
of Correia et al. They showed that kidney uptake in 
mice renal scintigraphy peaked 30 min after 99mTc-
DMSA injection, remained steady for 1 h, and 
declined quickly over the course of the study. In fact, 
they acquired images 0.5, 1, 5 and 12 h post-injection 
[20], whereas we followed each rat and continued to 
image the animals every 20 min for 8 h post-injection. 
Hence, our study provides more detailed 
understanding of the DMSA uptake during the early 
phase after injection.  
Maximum amount of the KBR reflects the contrast 
between the organ of interest and the surrounding 
tissue. Hence, the appropriate time for 99mTc-DMSA 
scintigraphy is the time at which renal uptake of 
radionuclide and KBR are at their maximum level. Our 
results showed that imaging in a time span of 1 to at 
least 8 h post-injection can produce similar results in 
terms of kidney to background count ratio. Also, it 
could be concluded that the appropriate time for 99mTc-
DMSA scintigraphy using low sensitivity imaging 
systems is between the 1st and the 2nd hours after 
radionuclide injection, because of the higher activity 
of the kidneys in this period. 
Taken together, the kidneys had maximum emission 
and CRPP between 1 to 2 h after 99mTc-DMSA 
injection. On the other hand, KBR remained constant 
after 1 h.  
 
CONCLUSION 
Image acquisition of 1-2 h post-injection is 
recommended for renal scintigraphy with 99mTc-
DMSA in rats. We studied the maximum uptake time 
of 99mTc-DMSA for 3 rats and more pre-clinical or 
clinical studies with larger samples are required to 
confirm the results of this study. 
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